Filing Details

Accession Number:
0001140361-22-036652
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-07 16:32:04
Reporting Period:
2022-10-06
Accepted Time:
2022-10-07 16:32:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1764013 Immunovant Inc. IMVT Pharmaceutical Preparations (2834) D0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635088 Ltd. Sciences Roivant Suite 1, 3Rd Floor
11-12 St. James'S Square
London X0 SW1Y 4LB
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Acquisiton 2022-10-06 416,667 $6.00 73,805,331 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct